CRMD has been in the news 1200% more than usual
Aug 15, 2024, 2:33 PM
45.09%
What does CRMD do
CorMedix, Inc., based in Berkeley Heights, New Jersey, specializes in developing and commercializing products like DefenCath, a solution to prevent infections in patients with central venous catheters. Founded in 2010, the company employs 40 people and explores taurolidine's potential in treating rare pediatric tumors.
CRMD has been in the news recently: CorMedix, Inc. reported $0.8 million in sales for Q2 2024 and experienced a net loss of $14.2 million, or 25 cents per share, during that period. The company has $59 million in cash with a 15-month cash runway, despite a 62% increase in cash burn to $46 million last year.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.